A new systematic literature search identified the highest priority clinical actions aimed at improving post-acute care for non-hospitalized traumatic brain injury (TBI). The study is published in the peer-reviewed Journal of Neurotrauma. The…


A new systematic literature search identified the highest priority clinical actions aimed at improving post-acute care for non-hospitalized traumatic brain injury (TBI). The study is published in the peer-reviewed Journal of Neurotrauma. The…
Researchers studied cerebral small vessel disease, a precursor for dementia, across thousands of participants from four distinct groups of middle-age to older adults, validating a biomarker that can help guide research on…
Concussions and repetitive head trauma in sports like football and boxing, once accepted as an unpleasant consequence of intense athletic competition, are now recognized as serious health threats. Of particular concern is…
Findings highlight potential significant role of certain medications in avoiding dementia A study led by the University of California, Irvine has found cardiovascular conditions such as high blood pressure and diabetes, which…
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response…
A new set of guidelines has been developed to assist with the diagnosis and expert management of serious blood cancers in pregnancy. About 12.5 pregnancies per 100,000 are affected by blood cancers…
Editor’s Note: On January 3rd, the U.S. Surgeon General released an advisory on Alcohol and Cancer Risk. The following is a commentary from Cynthia Bernal, Head of Wellness and Innovation for San…
Alcohol Consumption is the Third Leading Preventable Cause of Cancer in the United States Today, United States Surgeon General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol and Cancer Risk, outlining…
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence is taking over drug development,” claim…